Virus News and Research

Latest Virus News and Research

Canine COVID-19 vaccine could prevent reverse transmission of SARS-CoV-2

The new study, published in the journal Vaccines, reports on an attempt to use the SARS-CoV-2 spike subunit protein to elicit an immune reaction.

26 Apr 2022

The role of invasive alien species as a reservoir of pathogens

A new study published in the journal Ecological Indicators assessed pathogens and parasites carried by 118 invasive alien plant and animal species to bridge this knowledge gap. The European and Polish national legislatures regulated the majority of these species.

26 Apr 2022

Unhealthy air increases the chances of catching COVID-19

A Swedish study published in the journal JAMA Network Open investigates the association between short-term exposure to air pollution and SARS-CoV-2 infection.

26 Apr 2022

A novel mouse model to test SARS-CoV-2 viral infection

In a recent study posted to the Research Square* preprint server, researchers developed a novel mouse model for testing infection by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).

26 Apr 2022

Increased power and amplitude of memory B cells after SARS-CoV-2 mRNA booster

In a recent study published in the journal Nature, the researchers investigated the impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) booster vaccine on memory B cells.

25 Apr 2022

As vaccination coverage increases, SARS-CoV-2 genetic diversity decreases

In a recent letter to the editor published in the Journal of Infection, researchers from the Chinese PLA Center for Disease Control and Prevention observed that the genetic diversity of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) could be suppressed by high coverage of vaccination.

25 Apr 2022

COVID-19 vaccine can elicit a distinct T cell-dominant immune-mediated hepatitis

In a recent study published in the Journal of Hepatology, researchers reported that the coronavirus disease 2019 (COVID-19) vaccination could elicit a distinct T cell-dominant immune-mediated hepatitis.

25 Apr 2022

COVID-related hospital visitation limits may have contributed to increase in stress-related disorders

Efforts by hospitals to protect people from COVID-19 by restricting them from visiting family members in ICUs may have contributed to a significant increase in stress-related disorders, according to a study led by University of Colorado School of Medicine researchers.

25 Apr 2022

Common subcutaneous antibody therapy for immunodeficient patients has anti-SARS-CoV-2 antibodies

Researchers at the University of Texas Medical Branch recently confirmed the presence of neutralizing antibodies to SARS--COV-2 in a common subcutaneous antibody therapy (Hizentra) used to treat immunocompromised or immunodeficient patients, citing its protective benefits to the immunocompromised patient community.

25 Apr 2022

New COVID-19 vaccine proven to be safe and effective in late-stage clinical testing

A COVID-19 vaccine developed at the University of Washington School of Medicine has proven safe and effective in late-stage clinical testing.

25 Apr 2022

Despite losing federal money, California is still testing uninsured residents for covid — for now

California is still offering free covid testing to uninsured residents even though the federal government ran out of money to pay for it.

25 Apr 2022

Within-host model for the description of SARS-CoV-2 viral dynamics in the upper respiratory tract

A team of UK-based scientists has recently developed a within-host model to determine the dynamics of SARS-CoV-2 infection in the upper respiratory tract of affected individuals.

25 Apr 2022

World Malaria Day 2022: How the knockdown of P. falciparum RAP01 and RAP21 proteins could lead to novel antimalarial therapeutics

As part of World Malaria Day 2022, we interview Karine Le Roch PH.D., about her latest research into how novel antimalarial therapeutic strategies could be on the horizon, after identifying two proteins that are critical to the survival of the malaria parasite, Plasmodium falciparum.

25 Apr 2022

Anti-SARS-CoV-2 spike antibody levels following COVID-19 BNT162b2 vaccination

Researchers assessed factors influencing the anti-severe acute respiratory syndrome coronavirus 2 spike antibodies after SARS-CoV-2 BNT162b2 vaccination.

25 Apr 2022

Vaccine effectiveness against symptomatic disease caused by the Omicron and Delta variants in England

The researchers aimed to estimate how effective vaccination was against severe COVID-19, caused by Omicron and Delta variants of the virus, in England.

25 Apr 2022

The challenges of Omicron

A new review published in sums up the position of Omicron as a potential threat to human health, especially in the context of controlling this pandemic.

25 Apr 2022

Researchers identify five types of bacteria in men with aggressive prostate cancer

Researchers at the University of East Anglia have found a link between bacteria and aggressive forms of prostate cancer.

25 Apr 2022

Cross-reactive coronavirus antibodies might not be cross-neutralizing

In a recent study posted to Research Square* preprint server, researchers reported that cross-reactive antibodies against coronaviruses (CoVs) might not cross-neutralize all CoVs.

25 Apr 2022

Monoclonal-antibody combination AZD7442 prevents COVID-19

In a recent study published in The New England Journal of Medicine, the researchers examined the monoclonal-antibody combination AZD7442 to prevent coronavirus disease 2019 (COVID-19).

25 Apr 2022

Marine resources could be promising drug candidates against SARS-CoV-2 Omicron

A recent review paper, published in the MDPI’s specialized journal COVID, highlights key features of the Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – and examines the potential and roadblocks in using renewable marine resources in the fight against the coronavirus disease 2019 (COVID-19).

24 Apr 2022

Virus News and Research

Latest Virus News and Research

Canine COVID-19 vaccine could prevent reverse transmission of SARS-CoV-2

The role of invasive alien species as a reservoir of pathogens

Unhealthy air increases the chances of catching COVID-19

A novel mouse model to test SARS-CoV-2 viral infection

Increased power and amplitude of memory B cells after SARS-CoV-2 mRNA booster

As vaccination coverage increases, SARS-CoV-2 genetic diversity decreases

COVID-19 vaccine can elicit a distinct T cell-dominant immune-mediated hepatitis

COVID-related hospital visitation limits may have contributed to increase in stress-related disorders

Common subcutaneous antibody therapy for immunodeficient patients has anti-SARS-CoV-2 antibodies

New COVID-19 vaccine proven to be safe and effective in late-stage clinical testing

Despite losing federal money, California is still testing uninsured residents for covid — for now

Within-host model for the description of SARS-CoV-2 viral dynamics in the upper respiratory tract

World Malaria Day 2022: How the knockdown of P. falciparum RAP01 and RAP21 proteins could lead to novel antimalarial therapeutics

Anti-SARS-CoV-2 spike antibody levels following COVID-19 BNT162b2 vaccination

Vaccine effectiveness against symptomatic disease caused by the Omicron and Delta variants in England

The challenges of Omicron

Researchers identify five types of bacteria in men with aggressive prostate cancer

Cross-reactive coronavirus antibodies might not be cross-neutralizing

Monoclonal-antibody combination AZD7442 prevents COVID-19

Marine resources could be promising drug candidates against SARS-CoV-2 Omicron

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in